title: VHL deletion impairs mammary alveologenesis but is not sufficient for mammary tumorigenesis.
abstract: Overexpression of hypoxia inducible factor-1 (HIF-1)alpha, which is common in most solid tumors, correlates with poor prognosis and high metastatic risk in breast cancer patients. Because HIF-1alpha protein stability is tightly controlled by the tumor suppressor von Hippel-Lindau (VHL), deletion of VHL results in constitutive HIF-1alpha expression. To determine whether VHL plays a role in normal mammary gland development, and if HIF-1alpha overexpression is sufficient to initiate breast cancer, Vhl was conditionally deleted in the mammary epithelium using the Cre/loxP system. During first pregnancy, loss of Vhl resulted in decreased mammary epithelial cell proliferation and impaired alveolar differentiation; despite these phenotypes, lactation was sufficient to support pup growth. In contrast, in multiparous dams, Vhl(-/-) mammary glands exhibited a progressive loss of alveolar epithelium, culminating in lactation failure. Deletion of Vhl in the epithelium also impacted the mammary stroma, as there was increased microvessel density accompanied by hemorrhage and increased immune cell infiltration. However, deletion of Vhl was not sufficient to induce mammary tumorigenesis in dams bred continuously for up to 24 months of age. Moreover, co-deletion of Hif1a could not rescue the Vhl(-/-)-dependent phenotype as dams were unable to successfully lactate during the first lactation. These results suggest that additional VHL-regulated genes besides HIF1A function to maintain the proliferative and regenerative potential of the breast epithelium.
authors.affiliation: Department of Pathology and Laboratory Medicine, Center for Cancer Research, University of Tennessee Health Science Center, Memphis, TN 38163, USA. tseagro1@uthsc.edu
authors.forename: Tiffany N
authors.initials: TN
authors.lastname: Seagroves
authors.forename: Danielle L
authors.initials: DL
authors.lastname: Peacock
authors.forename: Debbie
authors.initials: D
authors.lastname: Liao
authors.forename: Luciana P
authors.initials: LP
authors.lastname: Schwab
authors.forename: Robin
authors.initials: R
authors.lastname: Krueger
authors.forename: Charles R
authors.initials: CR
authors.lastname: Handorf
authors.forename: Volker H
authors.initials: VH
authors.lastname: Haase
authors.forename: Randall S
authors.initials: RS
authors.lastname: Johnson
mesh_terms: D000818:Animals; D002454:Cell Differentiation; D049109:Cell Proliferation; D005260:Female; D017353:Gene Deletion; D015972:Gene Expression Regulation, Neoplastic; D008321:Mammary Glands, Animal / Q000473:pathology; D015674:Mammary Neoplasms, Animal / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D010641:Phenotype; D011247:Pregnancy; D011270:Pregnancy, Animal; D012306:Risk; D051794:Von Hippel-Lindau Tumor Suppressor Protein / Q000235:genetics*
chemical_list: D051794:Von Hippel-Lindau Tumor Suppressor Protein; C494469:VHL protein, mouse
references.citation: Nat Cell Biol. 2008 Oct;10(10):1208-16
references.pmid: 18806787
references.citation: Lancet. 2003 Jun 14;361(9374):2059-67
references.pmid: 12814730
references.citation: Cancer Res. 2000 Dec 15;60(24):7106-13
references.pmid: 11156418
references.citation: Mol Endocrinol. 2001 May;15(5):819-31
references.pmid: 11328861
references.citation: Oncogene. 2005 Jan 20;24(4):552-60
references.pmid: 15580303
references.citation: Exp Mol Med. 2005 Aug 31;37(4):353-64
references.pmid: 16155412
references.citation: Nat Cell Biol. 2007 Feb;9(2):210-7
references.pmid: 17220880
references.citation: Breast Cancer Res. 2004;6(6):R605-15
references.pmid: 15535842
references.citation: Semin Cell Dev Biol. 2005 Aug-Oct;16(4-5):564-74
references.pmid: 15908240
references.citation: Cancer Res. 2007 Jan 15;67(2):563-72
references.pmid: 17234764
references.citation: Microsc Res Tech. 2003 Feb 1;60(2):159-64
references.pmid: 12539169
references.citation: Mol Cell Biol. 2004 Sep;24(18):8037-47
references.pmid: 15340066
references.citation: Development. 2004 May;131(10):2497-508
references.pmid: 15128677
references.citation: Cancer Res. 2000 Aug 1;60(15):4010-5
references.pmid: 10945599
references.citation: Cell. 2007 May 4;129(3):465-72
references.pmid: 17482542
references.citation: Cancer Res. 2008 Jun 15;68(12):4674-82
references.pmid: 18559513
references.citation: Neoplasia. 2006 Aug;8(8):623-9
references.pmid: 16925945
references.citation: Int J Cancer. 2000 Nov 1;88(3):503-5
references.pmid: 11054685
references.citation: Tumour Biol. 2001 May-Jun;22(3):131-6
references.pmid: 11275790
references.citation: Development. 2003 Apr;130(8):1713-24
references.pmid: 12620994
references.citation: Cancer Res. 1999 Nov 15;59(22):5830-5
references.pmid: 10582706
references.citation: Methods Enzymol. 2007;435:87-105
references.pmid: 17998050
references.citation: Mol Endocrinol. 2000 Mar;14(3):359-68
references.pmid: 10707954
references.citation: Clin Cancer Res. 2006 Aug 1;12(15):4562-8
references.pmid: 16899602
references.citation: Dev Biol. 2007 Mar 1;303(1):29-44
references.pmid: 17222404
references.citation: Cancer. 2003 Mar 15;97(6):1573-81
references.pmid: 12627523
references.citation: Cancer Cell. 2009 Jun 2;15(6):501-13
references.pmid: 19477429
references.citation: Transgenic Res. 2001 Dec;10(6):545-53
references.pmid: 11817542
references.citation: Curr Opin Genet Dev. 2006 Feb;16(1):60-4
references.pmid: 16377171
references.citation: Nature. 2006 Feb 23;439(7079):993-7
references.pmid: 16395311
references.citation: Int J Cancer. 2005 Sep 20;116(5):734-9
references.pmid: 15849727
references.citation: Nucleic Acids Res. 1997 Nov 1;25(21):4323-30
references.pmid: 9336464
references.citation: Cancer Res. 1994 Jun 1;54(11):2852-5
references.pmid: 8187067
references.citation: PLoS One. 2009 Nov 03;4(11):e7669
references.pmid: 19888452
references.citation: J Natl Cancer Inst. 2001 Feb 21;93(4):309-14
references.pmid: 11181778
references.citation: Am J Nephrol. 2004 Jan-Feb;24(1):1-13
references.pmid: 14654728
references.citation: Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1583-8
references.pmid: 11171994
references.citation: Genesis. 2009 Apr;47(4):234-45
references.pmid: 19208431
references.citation: Adv Drug Deliv Rev. 2003 Apr 29;55(5):629-41
references.pmid: 12706546
references.citation: Breast Cancer Res. 2007;9(1):204
references.pmid: 17338830
references.citation: FASEB J. 2007 Dec;21(14):3994-4004
references.pmid: 17625068
references.citation: Cell. 2008 Apr 18;133(2):223-34
references.pmid: 18423195
references.citation: Annu Rev Nutr. 1999;19:407-36
references.pmid: 10448531
references.citation: Cancer Cell. 2008 Feb;13(2):141-52
references.pmid: 18242514
references.citation: Adv Anat Pathol. 2002 Jan;9(1):12-23
references.pmid: 11756756
references.citation: Cell Stem Cell. 2007 Oct 11;1(4):353-5
references.pmid: 18371369
references.citation: Dev Cell. 2005 Nov;9(5):617-28
references.pmid: 16256737
references.citation: FEBS Lett. 2007 Oct 2;581(24):4571-6
references.pmid: 17825299
references.citation: Mol Cell Biol. 2006 May;26(9):3514-26
references.pmid: 16611993
references.citation: Trends Mol Med. 2004 Apr;10(4):146-9
references.pmid: 15162797
references.citation: J Cell Physiol. 1998 Dec;177(3):439-52
references.pmid: 9808152
references.citation: Hum Pathol. 1997 Apr;28(4):459-64
references.pmid: 9104946
references.citation: Oncogene. 2004 Sep 9;23(41):6980-5
references.pmid: 15286714
references.citation: Int J Mol Med. 2007 Oct;20(4):605-11
references.pmid: 17786294
references.citation: Stem Cells. 2007 Mar;25(3):807-15
references.pmid: 17158237
references.citation: Gene Expr. 2003;11(3-4):181-97
references.pmid: 14686790
references.citation: Gynecol Oncol. 2002 Jan;84(1):186-7
references.pmid: 11749004
references.citation: Curr Opin Cell Biol. 2007 Dec;19(6):685-90
references.pmid: 18006292
references.citation: Oncogene. 2006 Jun 1;25(23):3325-34
references.pmid: 16434967
references.citation: Cancer Res. 2007 Oct 1;67(19):8980-4
references.pmid: 17908997
references.citation: Mol Cell Biol. 2004 Jun;24(12):5510-20
references.pmid: 15169911
references.citation: Genes Dev. 1998 Jun 15;12(12):1917-28
references.pmid: 9637692
references.citation: Int J Cancer. 2003 Jun 10;105(2):190-5
references.pmid: 12673678
references.citation: Development. 2002 Mar;129(6):1377-86
references.pmid: 11880347
references.citation: Cancer Res. 1998 Apr 1;58(7):1408-16
references.pmid: 9537241
references.citation: Nat Cell Biol. 2008 Mar;10(3):361-9
references.pmid: 18297059
references.citation: Cancer Res. 2006 Jun 1;66(11):5641-7
references.pmid: 16740701
references.citation: Nature. 2006 Jan 5;439(7072):84-8
references.pmid: 16397499
references.citation: Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9102-7
references.pmid: 9256442
references.citation: PLoS Med. 2006 Mar;3(3):e47
references.pmid: 16417408
references.citation: Mol Cell Biol. 2004 Apr;24(8):3251-61
references.pmid: 15060148
references.citation: Nat Genet. 1994 May;7(1):85-90
references.pmid: 7915601
references.citation: Cancer Res. 2003 Oct 1;63(19):6130-4
references.pmid: 14559790
references.citation: Cancer Res. 2006 Mar 1;66(5):2576-83
references.pmid: 16510575
references.citation: Mol Cell Biol. 2006 Apr;26(7):2519-30
references.pmid: 16537898